Jasper Therapeutics(JSPR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

JSPR Jasper Therapeutics

Market Closed 11-06 16:00:00 EST

16.86

+2.78

+19.78%

盘后16.86

+0.000.00%

19:56 EST

High17.00	Low12.76	Vol63.65K
Open12.76	D1 Closing14.08	Amplitude30.12%
Mkt Cap18.70M	Tradable Cap16.96M	Total Shares1.11M
T/O926.68K	T/O Rate6.33%	Tradable Shares1.01M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"JSPR","market":"US","secType":"STK","nameCN":"Jasper Therapeutics","latestPrice":16.86,"timestamp":1793998800000,"preClose":14.076,"halted":0,"volume":63650,"hourTrading":{"tag":"盘后","latestPrice":16.86,"preClose":16.86,"latestTime":"19:56 EST","volume":436,"amount":7460.6376,"timestamp":1794013016475,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.1977834612105711,"floatShares":1005780,"shares":1109153,"eps":-27.9,"marketStatus":"Market Closed","change":2.784,"latestTime":"11-06 16:00:00 EST","open":12.76,"high":17,"low":12.76,"amount":926684.4236,"amplitude":0.301222,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-27.9,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1794214800000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":14.076,"postHourTrading":{"tag":"盘后","latestPrice":16.86,"preClose":16.86,"latestTime":"19:56 EST","volume":436,"amount":7460.6376,"timestamp":1794013016475,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":3.926637,"impliedVol":2.816,"impliedVolPercentile":0.8964},"requestUrl":"/m/hq/s/JSPR/wiki","defaultTab":"wiki","newsList":[{"id":"2681882876","title":"Jasper Therapeutics trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2681882876","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681882876?lang=en_us&edition=fundamental","pubTime":"2026-11-06 08:50","pubTimestamp":1793926233,"startTime":"0","endTime":"0","summary":"19:50 EST Jasper Therapeutics (JSPR) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving brea...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jasper-therapeutics-trading-halted-news-pending-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jasper-therapeutics-trading-halted-news-pending-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680905184","title":"Jasper Therapeutics Announces 1-for-30 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2680905184","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680905184?lang=en_us&edition=fundamental","pubTime":"2026-11-04 21:00","pubTimestamp":1793797201,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nTUA7ZC8C8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675584669","title":"Jasper Therapeutics Completes IgA Nephropathy Enrollment in Phase 2 Vensobafusp Alfa Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2675584669","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675584669?lang=en_us&edition=fundamental","pubTime":"2026-10-15 20:07","pubTimestamp":1792066038,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics Completes IgA Nephropathy Enrollment in Phase 2 Vensobafusp Alfa TrialJasper Therapeutics completed IgA nephropathy enrollment in its Phase 2 renal basket trial of vensobafusp alfa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261015:nNDL9L7mPQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675858109","title":"Jasper Therapeutics Announces Completion of Enrollment in First Cohort of Phase 2 Renal Basket Study Evaluating Vensobafusp Alfa (Kp104) in Iga Nephropathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2675858109","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675858109?lang=en_us&edition=fundamental","pubTime":"2026-10-15 20:00","pubTimestamp":1792065604,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261015:nTUA1MT5NP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675584338","title":"Jasper Therapeutics - First Fsgs Patient in Phase 2 Study Expected to be Dosed in Q1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2675584338","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675584338?lang=en_us&edition=fundamental","pubTime":"2026-10-15 20:00","pubTimestamp":1792065604,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261015:nTUA1MT5NP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675584335","title":"Jasper Therapeutics - Initial Interim Data from Igan Study Expected by Year-End 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2675584335","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675584335?lang=en_us&edition=fundamental","pubTime":"2026-10-15 20:00","pubTimestamp":1792065604,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261015:nTUA1MT5NP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675320969","title":"Jasper Therapeutics files to sell 284.01M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2675320969","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675320969?lang=en_us&edition=fundamental","pubTime":"2026-10-15 05:25","pubTimestamp":1792013133,"startTime":"0","endTime":"0","summary":"This filing relates to the offer and sale from time to time by the selling stockholders of up to 284.01M shares of common stock. The company is not...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jasper-therapeutics-files-to-sell-284-01m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jasper-therapeutics-files-to-sell-284-01m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675234866","title":"Jasper Therapeutics resumed with an Outperform at William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2675234866","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675234866?lang=en_us&edition=fundamental","pubTime":"2026-10-14 17:50","pubTimestamp":1791971434,"startTime":"0","endTime":"0","summary":"William Blair resumed coverage of Jasper Therapeutics (JSPR) with an Outperform rating. The buy rating is based on the potential of Jasper’s bifunc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jasper-therapeutics-resumed-with-an-outperform-at-william-blair-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jasper-therapeutics-resumed-with-an-outperform-at-william-blair-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673015812","title":"Corrected-Jasper Therapeutics - Offer Purchase Price is $0.324 (Not '$0.32') in Cash Per Warrant","url":"https://stock-news.laohu8.com/highlight/detail?id=2673015812","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673015812?lang=en_us&edition=fundamental","pubTime":"2026-10-07 21:29","pubTimestamp":1791379747,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nL8N45T16O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673783090","title":"Jasper Therapeutics Launches Cash Tender Offer to Buy Back Outstanding Warrants for $0.324 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2673783090","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673783090?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:03","pubTimestamp":1791374582,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics launches cash tender offer to buy back outstanding warrants for $0.324 eachJasper Therapeutics launched a cash tender offer to buy any and all outstanding common stock purchase war","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nNDLzFnnH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BKPKM429.USD","BK4588","IE00BGHQF748.EUR","LU0314104364.USD","IE00BQXX3F31.USD","LU2210150020.SGD","IE00BQXX3C00.GBP","IE00BN0W2T93.GBP","BCDF","JSPR","LU2210149790.SGD","IE00BQXX3D17.EUR","BK4139","LU2095319765.USD","SG9999014039.USD","IE00BN0W2W23.USD","SG9999014021.USD","NDAQ","SG9999014013.SGD","BK4112","IE00BN0W2V16.EUR","SG9999014005.SGD","BK4585","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673909048","title":"Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2673909048","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673909048?lang=en_us&edition=fundamental","pubTime":"2026-10-07 20:00","pubTimestamp":1791374400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nTUARJGKR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673022777","title":"Jasper Therapeutics Holds Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2673022777","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673022777?lang=en_us&edition=fundamental","pubTime":"2026-10-05 20:10","pubTimestamp":1791202202,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics holds special shareholder meetingJasper Therapeutics held a special shareholder meeting on September 30, 2026.Shareholders backed a charter amendment authorizing the board to imple","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDL5CK2k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671501792","title":"Jasper Therapeutics - Appoints Jeet Mahal as Interim Principal Financial Officer Effective October 9, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2671501792","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671501792?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:45","pubTimestamp":1790628357,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45K0WT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671250455","title":"Jasper Therapeutics - Herb Cross Resigns as CFO and Corporate Secretary Effective October 9, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2671250455","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671250455?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:45","pubTimestamp":1790628357,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nFWN45K0WT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671178250","title":"Jasper Therapeutics CFO Herb Cross Resigns Effective Oct. 9","url":"https://stock-news.laohu8.com/highlight/detail?id=2671178250","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671178250?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:44","pubTimestamp":1790628293,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics CFO Herb Cross resigns effective Oct. 9Jasper Therapeutics CFO Herb Cross resigned effective Oct. 9 to pursue other professional opportunities.CEO Jeet Mahal was named interim principal financial officer effective with Cross’ departure.Vice President, Finance Rick Ruiz was appointed interim principal accounting officer; he joined in 2024 with 25+ years in accounting, FP&A, financing, SEC reporting.Chief Operating Officer Matthew Ros was named interim corporate secretary effective Oct. 9.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jasper Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Sec","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL6WyNtj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669485571","title":"H.C. Wainwright Remains a Buy on Jasper Therapeutics (JSPR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669485571","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669485571?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:35","pubTimestamp":1790069719,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Emily Bodnar maintained a Buy rating on Jasper Therapeutics yesterday and set a price target of $20.00. The company’s share...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-jasper-therapeutics-jspr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-remains-a-buy-on-jasper-therapeutics-jspr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667624934","title":"Press Release: Jasper Therapeutics Announces Key Regulatory and Clinical Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=2667624934","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667624934?lang=en_us&edition=fundamental","pubTime":"2026-09-16 04:05","pubTimestamp":1789502700,"startTime":"0","endTime":"0","summary":"Lisa Pitt, Pharm.D., M.S.J. appointed Senior Vice President, Regulatory AffairsShiguang Liu, M.D., Ph.D. appointed Vice President, Clinical DevelopmentREDWOOD CITY, Calif., Sept. 15, 2026 (GLOBE NEWSW","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JSPR","IND","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666538660","title":"Jasper Therapeutics to Join H.C. Wainwright Global Investment Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2666538660","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666538660?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:03","pubTimestamp":1788955405,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics to join H.C. Wainwright Global Investment Conference fireside chatJasper Therapeutics will participate in the H.C. Wainwright 28th Annual Global Investment Conference in New York o","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL9mJh62:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","LU2095319765.USD","JSPR","SG9999014021.USD","SG9999014039.USD","NDAQ","BK4588","IE00BQXX3D17.EUR","LU0314104364.USD","IE00BN0W2W23.USD","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014013.SGD","BCDF","IE00BQXX3C00.GBP","IE00BN0W2T93.GBP","BK4112","IE00BKPKM429.USD","LU2210150020.SGD","BK4139","IE00BQXX3F31.USD","IE00BN0W2V16.EUR","BK4585","IE00B64PRP62.GBP","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665935675","title":"Jasper Therapeutics Announces Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2665935675","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665935675?lang=en_us&edition=fundamental","pubTime":"2026-09-05 03:09","pubTimestamp":1788548952,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics announces special shareholder meetingJasper Therapeutics will hold a virtual special stockholder meeting on Sept. 30, 2026.Shareholders will vote on a potential reverse stock split","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL8lSSCL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JSPR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662820960","title":"Jasper Therapeutics Announces Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2662820960","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662820960?lang=en_us&edition=fundamental","pubTime":"2026-08-25 05:31","pubTimestamp":1787607101,"startTime":"0","endTime":"0","summary":"Jasper Therapeutics announces special shareholder meetingJasper Therapeutics will hold a virtual special shareholder meeting on Sept. 30, 2026.Vote on a reverse stock split within a 1-for-15 to 1-for-","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL7r4H4t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","JSPR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jaspertherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0804},{"period":"1month","weight":-0.0135},{"period":"3month","weight":-0.2079},{"period":"6month","weight":-0.3933},{"period":"1year","weight":-0.6929},{"period":"ytd","weight":-0.6929}],"compareEarnings":[{"period":"1week","weight":-0.027},{"period":"1month","weight":-0.0539},{"period":"3month","weight":-0.0491},{"period":"6month","weight":-0.0032},{"period":"1year","weight":0.0969},{"period":"ytd","weight":0.0783}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of therapeutic agents for diseases, such as chronic spontaneous urticaria, lower to intermediate risk myelodysplastic syndrome, and novel conditioning regimens for stem cell transplantation and ex-vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company's lead product candidate is briquilimab, which is in clinical development as a novel therapeutic antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is headquartered in Redwood City, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.285776},{"month":2,"riseRate":0.428571,"avgChangeRate":0.093912},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.063229},{"month":4,"riseRate":0.571429,"avgChangeRate":-0.031704},{"month":5,"riseRate":0.714286,"avgChangeRate":0.025166},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.150942},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.014598},{"month":8,"riseRate":0.571429,"avgChangeRate":0.012042},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.208701},{"month":10,"riseRate":0.142857,"avgChangeRate":-0.038546},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.048296},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.008174}],"exchange":"NASDAQ","name":"Jasper Therapeutics","nameEN":"Jasper Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Jasper Therapeutics(JSPR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Jasper Therapeutics(JSPR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Jasper Therapeutics,JSPR,Jasper Therapeutics股票,Jasper Therapeutics股票老虎,Jasper Therapeutics股票老虎国际,Jasper Therapeutics行情,Jasper Therapeutics股票行情,Jasper Therapeutics股价,Jasper Therapeutics股市,Jasper Therapeutics股票价格,Jasper Therapeutics股票交易,Jasper Therapeutics股票购买,Jasper Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Jasper Therapeutics(JSPR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Jasper Therapeutics(JSPR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}